China SXT Pharmaceuticals (SXTC) Other Gross PP&E Adjustments: 2018-2025
- China SXT Pharmaceuticals' Other Gross PP&E Adjustments rose 29.94% to -$149,278 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 11.98%. This contributed to the annual value of $2.2 million for FY2025, which is 1.12% down from last year.
- Latest data reveals that China SXT Pharmaceuticals reported Other Gross PP&E Adjustments of -$149,278 as of Q3 2025, which was down 106.69% from $2.2 million recorded in Q1 2025.
- China SXT Pharmaceuticals' Other Gross PP&E Adjustments' 5-year high stood at $2.7 million during Q1 2022, with a 5-year trough of -$358,569 in Q3 2021.
- In the last 3 years, China SXT Pharmaceuticals' Other Gross PP&E Adjustments had a median value of $876,664 in 2023 and averaged $961,467.
- Per our database at Business Quant, China SXT Pharmaceuticals' Other Gross PP&E Adjustments skyrocketed by 767.43% in 2022 and then slumped by 110.91% in 2023.
- Quarterly analysis of 5 years shows China SXT Pharmaceuticals' Other Gross PP&E Adjustments stood at -$358,569 in 2021, then spiked by 767.43% to $2.4 million in 2022, then crashed by 110.91% to -$261,108 in 2023, then increased by 18.40% to -$213,068 in 2024, then climbed by 29.94% to -$149,278 in 2025.
- Its Other Gross PP&E Adjustments was -$149,278 in Q3 2025, compared to $2.2 million in Q1 2025 and -$213,068 in Q3 2024.
